Review: Skin Tests Can Diagnose Contrast Media Hypersensitivity

This article originally appeared here.
Share this content:
Review: Skin Tests Can Diagnose Contrast Media Hypersensitivity
Review: Skin Tests Can Diagnose Contrast Media Hypersensitivity

(HealthDay News) -- For patients with hypersensitivity reaction (HSR) to iodinated contrast media (ICM), skin tests can be helpful for diagnosis, according to a meta-analysis published online Feb. 3 in Allergy.

Soon Ho Yoon, M.D., from Seoul National University College of Medicine in South Korea, and colleagues conducted a systematic review of the literature to examine the outcomes of skin tests performed in patients with HSR to ICM. Data were included from 21 studies.

The researchers found that the pooled per-patient positive rates of skin tests were 17 percent and up to 52 percent in patients with immediate HSR and when confined to severe immediate HSR, respectively. The positive rate was 26 percent among patients with non-immediate HSR. In non-immediate HSR, the pooled per-patient cross-reactivity rate was higher than in immediate HSR (68 versus 39 percent). Between pairs of ICM, the median per-test cross-reactivity rates were 7 percent in immediate HSR and 38 percent in non-immediate HSR. In immediate and non-immediate HSR, the pooled per-patient recurrence rates of HSR to skin test-negative ICM were 7 and 35 percent, respectively.

"Skin tests may be helpful in diagnosing and managing patients with HSR to ICM, especially in patients with severe immediate HSR," the authors write.

One author disclosed financial ties to the medical device industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »